Edition:
United Kingdom

Agios Pharmaceuticals Inc (AGIO.OQ)

AGIO.OQ on NASDAQ Stock Exchange Global Select Market

62.75USD
25 Mar 2019
Change (% chg)

$0.46 (+0.74%)
Prev Close
$62.29
Open
$62.15
Day's High
$62.95
Day's Low
$61.18
Volume
90,005
Avg. Vol
191,705
52-wk High
$99.77
52-wk Low
$41.63

About

Agios Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group of over 600 rare genetic diseases caused by mutations, or defects, of single metabolic genes. The Company's cancer product candidates are... (more)

Overall

Beta: 1.94
Market Cap(Mil.): $3,409.16
Shares Outstanding(Mil.): 48.39
Dividend: --
Yield (%): --

Financials

  AGIO.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -6.31 -- --
ROI: -46.41 8.89 13.82
ROE: -67.30 10.02 15.24

Earnings vs. Estimates